Immuneering
IMRX
Immuneering (IMRX) earnings history
Most recent quarter
- Fiscal period
- Q3 2025
- Period end
- Sep 30, 2025
- EPS actual
- −$0.38
- EPS estimate
- −$0.39
- EPS surprise
- +2.14%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $0.00
- Reported
- Nov 12, 2025
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q3 2025 | Nov 12, 2025 | −$0.39 | −$0.38 | +2.14% | $0.00 | SEC |
| Q2 2025 | Aug 13, 2025 | −$0.40 | −$0.40 | +0.07% | $0.00 | SEC |
| Q1 2025 | May 5, 2025 | −$0.53 | −$0.42 | +20.26% | $0.00 | SEC |
| Q4 2024 | Mar 20, 2025 | −$0.42 | −$0.58 | −39.42% | $0.00 | SEC |
| Q3 2024 | Nov 13, 2024 | −$0.55 | −$0.49 | +11.22% | $0.00 | SEC |
| Q2 2024 | Aug 6, 2024 | −$0.52 | −$0.47 | +9.62% | $0.00 | SEC |
| Q1 2024 | May 7, 2024 | −$0.50 | −$0.49 | +2.57% | $0.00 | SEC |
| Q4 2023 | Mar 1, 2024 | −$0.46 | −$0.52 | −12.34% | $0.00 | SEC |
| Q3 2023 | Nov 9, 2023 | −$0.49 | −$0.43 | +12.03% | $0.00 | SEC |
| Q2 2023 | Aug 3, 2023 | −$0.53 | −$0.43 | +18.48% | $0.00 | SEC |
| Q1 2023 | May 4, 2023 | −$0.54 | −$0.51 | +5.78% | $0.00 | SEC |
| Q4 2022 | Mar 6, 2023 | −$0.56 | −$0.50 | +10.94% | $456.00 | SEC |
| Q3 2022 | Nov 10, 2022 | −$0.48 | −$0.49 | −2.08% | $38,380.00 | SEC |
| Q2 2022 | Aug 10, 2022 | −$0.51 | −$0.44 | +14.21% | $94,419.00 | SEC |
| Q1 2022 | May 10, 2022 | −$0.44 | −$0.49 | −11.80% | $183,698.00 | SEC |
| Q4 2021 | Mar 10, 2022 | −$0.39 | −$0.42 | −8.81% | $189,591.00 | SEC |
| Q3 2021 | Nov 9, 2021 | −$0.56 | −$0.47 | +16.44% | $482,130.00 | SEC |
| Q2 2021 | Sep 9, 2021 | −$1.66 | −$1.61 | +2.72% | $660,040.00 | SEC |
Quarterly revenue
Frequently asked questions
When did Immuneering (IMRX) last report earnings?
Immuneering last reported on Nov 12, 2025, covering fiscal Q3 2025.
Did IMRX beat earnings estimates?
Yes. Immuneering reported EPS of −$0.38 for Q3 2025 against a −$0.39 estimate — a 2.14% beat.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.